Analyst Ratings for Barinthus Biotherapeutics (BRNS)

BRNS Rating Summary

BRNS Price Target Summary

* Over Last 12-Mos
  |   Expand Research on BRNS
Overall Rating: SELL   Rating Trend: =   Avg. $ Target: $4.00 (+566.7%) * Over Last 12-Mos
Rating Score: 0 / 10   Percentile Rank: 0%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details